GBG Participation at ESMO 2025 in Berlin
This year, GBG will once again present the latest results of GBG studies:
Mini oral presentation: “Durvalumab in Combination with Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC) – Long-term Analysis from the GeparNuevo Trial” presented by Sibylle Loibl
Poster presentation: “HER2 IHC Status of Primary Breast Cancer Tumor and Brain Metastases in the BMBC Registry” presented by Elena Laakmann
Look forward to more information soon...
